Current Issue: Featured Articles

Kasey-Damato-headshot-v2
Life and Career Coaching for NPs and PAs—The Next Frontier: APPs Starting to Embrace Practice Ownership
by Kasey D’Amato, PA-C, MPAP, and Kathryn Werner, PA-C Ms. D’Amato is President of Certified PA Consulting in Ft. Lauderdale, Florida. Ms. Werner is Practice Owner, Senior Business Consultant, Certified...
DelleChiaie_Headshot
Diplopia Secondary to Neurotoxin Injections: Prevention, Diagnosis, and Management
By Tara Delle Chiaie, DNP, MSN, FNP-BC, APRN Tara is the owner of Delle Chiaie Cosmetic Medicine and Delle Chiaie Concierge Medicine as well as the founder and principal instructor of DCCM™ Academy, an...
Kasey-Damato-headshot-v2
Life and Career Coaching for NPs and PAs— Negotiating Success for Advanced Practice Practitioners: Strategies for Dealing with a Challenging Boss
by Kasey D’Amato, PA-C, MPAP Ms. D’Amato is President of Certified PA Consulting in Ft. Lauderdale, Florida. J Clin Aesthet Dermatol. 2023;17(1–2 Suppl 1):S42–S43. FUNDING: No funding was provided for...
GDPAAbstracts_Image
Selected Poster Abstracts from 15th Annual Dermatology Pearls Conference
J Clin Aesthet Dermatol. 2024;17(1–2 Suppl 1):S33–S37. Atopic Dermatitis Efficacy and safety of roflumilast cream 0.15% in adults and children aged ≥6 with mild-to-moderate atopic dermatitis in two Phase...
Elevate-DermAbstracts_Image
Selected Poster Abstracts from 4th Annual Elevate-Derm PA & NP Conference
J Clin Aesthet Dermatol. 2024;17(1–2 Suppl 1):S15–S30. Acne Early and sustained reductions in moderate-to-severe acne with fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15%...

Atopic Dermatitis Advisor Audio Series:

Incorporating Topical and Oral Treatments into Practice

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.